22m
DiaMedica Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Highlights
DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for preeclampsia (PE), fetal growth restriction and acute ischemic stroke ...
The healthcare sector faces an array of complex cyber risk considerations involving artificial intelligence. The Health ...
Nonprofits like Second Harvest Food Bank of Metrolina and NourishUp are working to respond to the halt in SNAP benefits amid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback